Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Prepaid Assets for 3 consecutive years, with $238000.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 96.78% to $238000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238000.0 through Dec 2025, down 96.78% year-over-year, with the annual reading at $238000.0 for FY2025, 96.78% down from the prior year.
  • Prepaid Assets for Q4 2025 was $238000.0 at Inhibrx Biosciences, down from $7.5 million in the prior quarter.
  • The five-year high for Prepaid Assets was $16.7 million in Q4 2023, with the low at $238000.0 in Q4 2025.
  • Average Prepaid Assets over 3 years is $5.9 million, with a median of $4.1 million recorded in 2024.
  • Peak annual rise in Prepaid Assets hit 902.41% in 2025, while the deepest fall reached 97.95% in 2025.
  • Over 3 years, Prepaid Assets stood at $16.7 million in 2023, then tumbled by 55.68% to $7.4 million in 2024, then tumbled by 96.78% to $238000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $238000.0, $7.5 million, and $283000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.